Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 5
1995 4
1996 1
1997 1
2000 1
2001 1
2002 1
2003 1
2004 1
2005 5
2006 2
2007 3
2008 2
2009 2
2010 7
2011 1
2012 3
2013 5
2014 8
2015 6
2016 8
2017 7
2018 3
2019 1
2020 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.
Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. Hsu IC, et al. Among authors: gottschalk ar. Brachytherapy. 2014 Jan-Feb;13(1):27-31. doi: 10.1016/j.brachy.2013.11.007. Epub 2013 Dec 22. Brachytherapy. 2014. PMID: 24368283 Review.
ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.
McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ; Expert Panel on Radiation OncologyProstate. McLaughlin PW, et al. Among authors: gottschalk ar. Am J Clin Oncol. 2017 Feb;40(1):1-10. doi: 10.1097/COC.0000000000000354. Am J Clin Oncol. 2017. PMID: 28059930
Bcl-2 and Bcl-2-related proteins in apoptosis regulation.
Boise LH, Gottschalk AR, Quintáns J, Thompson CB. Boise LH, et al. Among authors: gottschalk ar. Curr Top Microbiol Immunol. 1995;200:107-21. doi: 10.1007/978-3-642-79437-7_8. Curr Top Microbiol Immunol. 1995. PMID: 7634826 Review.
ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.
Expert Panel on Radiation Oncology-Prostate:; Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. Expert Panel on Radiation Oncology-Prostate:, et al. Among authors: gottschalk ar. Adv Radiat Oncol. 2016 Oct 20;2(1):62-84. doi: 10.1016/j.adro.2016.10.002. eCollection 2017 Jan-Mar. Adv Radiat Oncol. 2016. PMID: 28740916 Free PMC article. Review. No abstract available.
ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.
Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ; American College of Radiology, Expert Panel on Radiation OncologyProstate. Nguyen PL, et al. Among authors: gottschalk ar. Am J Clin Oncol. 2014 Jun;37(3):278-88. doi: 10.1097/COC.0000000000000049. Am J Clin Oncol. 2014. PMID: 25180754 Review.
ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.
Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. Zaorsky NG, et al. Among authors: gottschalk ar. Adv Radiat Oncol. 2017 Mar 20;2(3):437-454. doi: 10.1016/j.adro.2017.03.003. eCollection 2017 Jul-Sep. Adv Radiat Oncol. 2017. PMID: 29114613 Free PMC article. Review.
72 results